PL3782999T3 - Sposób syntetyzowania pochodnej 3-fenylo-2,8-dihydropirano[2,3- f]chromenu - Google Patents

Sposób syntetyzowania pochodnej 3-fenylo-2,8-dihydropirano[2,3- f]chromenu

Info

Publication number
PL3782999T3
PL3782999T3 PL19782372.7T PL19782372T PL3782999T3 PL 3782999 T3 PL3782999 T3 PL 3782999T3 PL 19782372 T PL19782372 T PL 19782372T PL 3782999 T3 PL3782999 T3 PL 3782999T3
Authority
PL
Poland
Prior art keywords
dihydropyrano
synthesizing
phenyl
chromene derivative
chromene
Prior art date
Application number
PL19782372.7T
Other languages
English (en)
Inventor
Sang Ku Yoo
Jin Wook Chung
In Geun Jo
Ji Young Kim
Jeong Ho Im
Ku Suk Kang
Jin Young Kim
Original Assignee
Glaceum, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaceum, Inc. filed Critical Glaceum, Inc.
Publication of PL3782999T3 publication Critical patent/PL3782999T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL19782372.7T 2018-04-03 2019-04-03 Sposób syntetyzowania pochodnej 3-fenylo-2,8-dihydropirano[2,3- f]chromenu PL3782999T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20180038894 2018-04-03
PCT/KR2019/003958 WO2019194582A1 (ko) 2018-04-03 2019-04-03 3-페닐-2,8-디히드로피라노[2,3-f]크로멘 유도체의 합성 방법

Publications (1)

Publication Number Publication Date
PL3782999T3 true PL3782999T3 (pl) 2023-08-14

Family

ID=68100957

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19782372.7T PL3782999T3 (pl) 2018-04-03 2019-04-03 Sposób syntetyzowania pochodnej 3-fenylo-2,8-dihydropirano[2,3- f]chromenu

Country Status (12)

Country Link
US (1) US11420978B2 (pl)
EP (1) EP3782999B1 (pl)
JP (1) JP7350771B2 (pl)
KR (1) KR102795511B1 (pl)
CN (1) CN111989330B (pl)
AR (1) AR121418A1 (pl)
CA (1) CA3094086A1 (pl)
DK (1) DK3782999T3 (pl)
ES (1) ES2948635T3 (pl)
PL (1) PL3782999T3 (pl)
TW (1) TWI804600B (pl)
WO (1) WO2019194582A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230146461A (ko) 2022-04-12 2023-10-19 주식회사 글라세움 3-페닐-2,3,4,8,9,10-헥사히드로피라노[2,3-f]크로멘 유도체의 합성 방법
CN119192191B (zh) * 2024-11-25 2025-03-04 山东第一医科大学(山东省医学科学院) 甲氧基化光甘草定类似物及其制备方法及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100565423B1 (ko) * 2003-10-20 2006-03-30 빅 바이오 주식회사 이소플라반 유도체 또는 이소플라벤 유도체의 제조방법
JP2006008605A (ja) * 2004-06-25 2006-01-12 Kuraray Co Ltd イソフラバノン誘導体の製造方法
JP2006008604A (ja) * 2004-06-25 2006-01-12 Kuraray Co Ltd イソフラバン誘導体の製造方法
WO2006085562A1 (ja) * 2005-02-09 2006-08-17 Kaneka Corporation メタボリックシンドローム及びインスリン抵抗性症候群の予防及び／又は処置用組成物
CN103030647B (zh) * 2013-01-16 2014-10-29 山东省分析测试中心 一种光甘草定的合成方法
KR102344479B1 (ko) * 2013-12-24 2021-12-29 주식회사 글라세움 피라노크로메닐페놀 유도체, 및 대사증후군 또는 염증 질환 치료용 약학 조성물
US10669282B2 (en) * 2016-10-04 2020-06-02 Glaceum, Inc. Method for synthesizing 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2.3-f]chromene derivative and optical isomer of thereof
KR20180038894A (ko) 2016-10-07 2018-04-17 이은지 황금비율 이동식 테이블

Also Published As

Publication number Publication date
AR121418A1 (es) 2022-06-08
ES2948635T3 (es) 2023-09-15
CN111989330A (zh) 2020-11-24
KR20190116100A (ko) 2019-10-14
JP7350771B2 (ja) 2023-09-26
JP2021520361A (ja) 2021-08-19
KR102795511B1 (ko) 2025-04-16
US20210040106A1 (en) 2021-02-11
DK3782999T3 (da) 2023-08-07
CA3094086A1 (en) 2019-10-10
US11420978B2 (en) 2022-08-23
CN111989330B (zh) 2023-07-25
TW202003523A (zh) 2020-01-16
EP3782999A1 (en) 2021-02-24
WO2019194582A1 (ko) 2019-10-10
EP3782999A4 (en) 2021-12-22
EP3782999B1 (en) 2023-05-10
TWI804600B (zh) 2023-06-11

Similar Documents

Publication Publication Date Title
ZA201902760B (en) Method for synthesizing 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivative and optical isomer of thereof
IL292754A (en) Method of synthesis
IL280295A (en) Effective method for manufacturing antibody-drug conjugate
PL3958977T3 (pl) Pochodne kamptotecyny
IL285729B (en) Pyran dervatives as cyp11a1 (cytochrome p450 monooxygenase 11a1) inhibitors
DK3433256T3 (da) 6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinolinderivat, der er anvendeligt til behandling af cancer
DK3312177T3 (da) Tricyklisk derivatforbindelse, fremgangsmåde til at fremstille samme og farmaceutisk sammensætning omfattende samme
EA201792067A1 (ru) Противогрибковые соединения и способы получения
HUE049606T2 (hu) Eljárás flavonoid inklúziós vegyületek elõállítására
PL3502105T3 (pl) Postać polimorficzna związku stanowiącego inhibitor kinazy, zawierająca ją kompozycja farmaceutyczna oraz sposób jej wytwarzania i jej zastosowanie
HUE057666T2 (hu) Eljárás 4-metoxipirrol-származék köztiterméke elõállítására
EP3884940A4 (en) Novel imidazole derivative
IL276887A (en) History of novel chromium as TCR-NCK interaction inhibitors
PL3952858T3 (pl) Sposób leczenia guzów
EP3824071A4 (en) BIOSYNTHETIC MANUFACTURE OF GAMMA LACTONES
EP3354648A4 (en) 4-SUBSTITUTED CUMARINE DERIVATIVE AND METHOD OF PREPARATION AND USE THEREOF
DK3749668T3 (da) Kontinuerlig fremgangsmåde til fremstilling af trazodonbase
PL3487859T3 (pl) Przeciwprzerzutowe 2h-selenofeno[3,2-H]chromeny, ich synteza i sposoby stosowania takich środków
EP3677572C0 (en) Production method for pyrazole-4-carboxamide derivative
HUE055374T2 (hu) Eljárás Lenvatinib elõállítására
DK3782999T3 (da) Fremgangsmåde til syntetisering af 3-phenyl-2,8-dihydropyrano-[2,3-f]-chromenderivat
DK3515454T3 (da) Krystallinsk polymorf form af 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2lambda5-[1,2]oxaphosphinan
DK3917972T3 (da) Fremgangsmåde til at frembringe hæmmet stivelse
DK3864016T3 (da) Fremgangsmåde til fremstilling af substituerede imidazolderivater
DK3645509T3 (da) Fremgangsmåde til fremstilling af substituerede 4-aminoindanderivater